English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Why Attend ADLM 2024?
Immerse yourself in a state-of-the-art medical conference, all while embracing the captivating allure of the city. Chicago seamlessly combines enlightenment and excitement for an unforgettable experience. Sign up for the latest information about events happening at our booth.
Reimagining Diagnostics
From uncovering the next clinical breakthrough, to rapid and reliable sample analysis, to more rigorous decision making—at Beckman Coulter we are providing actionable insights that inform clinical decisions during critical moments. From the laboratory to the clinician to the patient, together we are powering the moments that matter.
Visit us at booth 2803 to experience how we’re bringing this vision to life.
All
Explore Innovations in Clinical Diagnostics
From innovative biomarkers to informatics and automation, below is a preview of a few of the solutions that will be on display at ADLM. Contact your sales representative to schedule a booth tour and learn more about what’s in store at Beckman Coulter.
Pioneering Digital Hematology
Discover what we’re doing to deliver more insights from the CBC.
Learn more
Biomarker Innovation
Explore what’s available and on the horizon in biomarker innovation, including MDW for sepsis detection.
Learn more
Tour the DxI 9000 Immunoassay Analyzer* with ZeroDaily Maintenance. A high-throughput, high-sensitivity immunoassay analyzer designed to power lab performance across health systems.
Learn more
Advantaged Workflow
See how to expedite patient care and enhance laboratory efficiency with automated clinical laboratory systems.
Learn more
CLIA 2024: Are You Worried or Are You Ready?
With the July changes to CLIA PT goals, laboratories face an unprecedented challenge. PT expenses and failures will go up, but this pain will not be felt equally across methods, instruments, and laboratories. Necessarily, some instruments and methods will need more stringent QC. Before the failures impact laboratory operations, it’s critical to assess the ability of methods to pass the new PT QC and to implement optimal QC.
Presented by:
Sten Westgard
Director of Client Services and Technology
Westgard QC, Inc.
Date: Wednesday, July 31
Time: 7:00 am – 8:30 am
Location: Hyatt Regency McCormick Place, Chicago, IL
Room: Hyde Park
This event is popular! Space is limited--RSVP today.
Join our In-Booth Presentations
Value of Monocyte Distribution Width in Bacteremia Assessment of Emergency Department Patients
Speaker: Dr. Bernard Cook, Henry Ford Health System
Learn how the combination of host response parameters like Monocyte Distribution Width along with pathology detection methods such as blood cultures can give you better risk stratification among blood patients, ultimately positively impacting patient care.
Tuesday, July 30th at 3:15pm
First of Its Kind High Sensitivity Immunoassay Testing Capabilities
Speakers: Sean Roberts & Shannon Garegnani, Beckman Coulter Diagnostics
Experience the future of immunoassay testing with the DxI 9000 Immunoassay Analyzer*, offering first-of-its-kind high sensitivity capabilities. With over 250 patents and pending applications, this innovative technology delivers improved analytical sensitivity, signal detection, and enhanced precision. Learn about the performance of our Access HIV Ag/Ab Combo and Access HsTnI assays and how the DxI 9000 anaylzer achieves remarkable six sigma performance across all analytes.
Wednesday, July 31st at 2:00pm
Attend Poster Sessions
Posters will be presented in the Poster Hall on Expo show floor between 9:30 a.m. and 5:00 p.m. on Tuesday, July 30 and Wednesday, July 31. Presenting authors will be in attendance from 1:30 to 2:30 p.m. each day. Select posters presentations are listed below:
July 30, 2024, 9:30 AM - 5:00 PM
- A-003. Beckman Coulter DxI9000 Immunoassay Analyzer’s High Sensitivity Troponin I achieves >90% Six Sigma performance when assessed against CLIA 2024 goals.
See abstract > - A-306. High sensitivity capability of an Anti-Müllerian Hormone assay on the Beckman Coulter DxI 9000 Immunoassay Analyzer*, a next step toward enabling ovarian failure staging?
See abstract > - A-292. Validation of Aztreonam-Avibactam MIC Antimicrobial Susceptibility Test for MicroScan Dried Gam-Negative MIC Panels from a Multicenter Assessment of Enterobacterales and Stenotrophomonas maltophilia.
See abstract >
July 31, 2024, 9:30 AM - 5:00 PM
- B-113. Beckman Coulter DxI 9000 Immunoassay Analyzer assay performance meets new CLIA 2024 PT goals with highest proportion of Six Sigma performance amongst manufacturers.
See abstract > - B-005. Improved sensitivity on the Beckman Coulter DxI 9000 Immunoassay Analyzer* enables reduction of required sample and reagent volumes for immunoassays.
See abstract >- This poster has been selected for a brief poster presentation and Q&A in a session immediately following the poster session.
- B-058. Multicenter evaluation of the new Access HIV Ag/Ab combo assay with highly sensitive HIV-1 p24 antigen detection on the DxI 9000 Access Immunoassay Analyzer.
See abstract >
More information coming soon!
Sign up below to receive information about our exciting events.
Get Ready to Explore
Discover all that Chicago has to offer at ADLM 2024
Sign up to Receive the Latest
Event Info
Thank you for your request.
*Full name DxI 9000 Access Immunoassay Analyzer
